NIPH Clinical Trials Search

JRCT ID: jRCT1030220526

Registered date:23/12/2022

Analysis of phosphoinositide variants in gynecological cancers

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedovarian cancer, endometrial cancer, cervical cancer
Date of first enrollment23/12/2022
Target sample size250
Countries of recruitment
Study typeObservational


Primary OutcomeLevels of phosphoinositide variants in tumor tissue, ascites, or blood samples, results of genomic profiling by oncopanel testing, age, histopathological diagnosis, stage, overall survival, cancer-specific survival, progression-free survival, recurrence-free survival, treatment-free interval, and therapeutic efficacy, etc.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
Include criteriaPatients who received surgeries for ovarian cancer, endometrial cancer, or cervical cancer at our hospital between the date of approval by the review board and September 30, 2027, and whose tumor tissue, ascites, or blood samples are stored at the Tsukuba Human Tissue Biobank Center.
Exclude criterianone

Related Information


Public contact
Name Takeo Minaguchi
Address 2-1-1 Amakubo, Tsukuba, Ibaraki Ibaraki Japan 305-8576
Telephone +81-29-853-3073
Affiliation University of Tsukuba Hospital
Scientific contact
Name Toyomi Satoh
Address 1-1-1 Tennoudai, Tsukuba, Ibaraki Ibaraki Japan 305-8575
Telephone +81-29-853-3049
Affiliation Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba